METHYLPARABEN SODIUM
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 152.0 | 1.2 | 1 | 3 | 47.0 | 1 | 0.12 |
- CAS
- 5026620
- UNII
- CR6K9C2NHK
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 80 ZINC catalogs
Known Active Genes
This compound has been observed to have activity at 10μM or less against the following gene(s).
| Name | Description | Classification |
|---|---|---|
| CA12 | Carbonic anhydrase 12 | Enzyme / Lyase |
| CA9 | Carbonic anhydrase 9 | Enzyme / Lyase |
| CA14 | Carbonic anhydrase 14 | Enzyme / Lyase |
| CA1 | Carbonic anhydrase 1 | Enzyme / Lyase |
| CA7 | Carbonic anhydrase 7 | Enzyme / Enzyme-Other |
| CA2 | Carbonic anhydrase 2 | Enzyme / Enzyme-Other |
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 0.27MG |
| Oral | Tablet | 0.19MG |
| Oral | Tablet, Orally Disintegrating | 0.3MG |
| Oral | Powder, For Oral Suspension | |
| Oral | Powder, For Suspension | |
| Oral | Solution | |
| Oral | Suspension |